Cacelín GJR, Cacelín MRS, Cacelín MAR, Melendez OJA, Rodríguez GM, Temoltzin JS, Zanjuampa CE, de la Cuesta BYG, Pérez SJA

Language: Spanish
References: 18
Page: 26-36
PDF size: 274.07 Kb.

ABSTRACT

Infection by SARS-CoV-2 virus is not solely limited to the common clinical presentation of acute respiratory distress syndrome, mainly because a wide spectrum of clinical manifestation has been observed. These presentations include, but are not limited to, neurological, cardiovascular, thromboembolic, hematologic, and autoimmune presentations. Within this wide spectrum, cases of autoimmune hemolytic anemia due to SARS-CoV-2 infection are rising. This is why primary care physicians should be ready to identify this clinical entity appropriately.

REFERENCES

1. Barcellini W, Fattizzo B. Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia. Dis Markers. 2015;2015:635670.

2. Phillips J, Henderson AC. Hemolytic Anemia: Evaluation and Differential Diagnosis. Am Fam Physician. 2018 Sep;98(6):354-61.

3. Brodsky RA. Warm Autoimmune Hemolytic Anemia. N Engl J Med. 2019 Aug;381(7):647-54.

4. Jäger U, Barcellini W, Broome CM, Gertz MA, Hill A, Hill QA, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev. 2020 May;41:100648.

5. Hill A, Hill QA. Autoimmune hemolytic anemia. Hematol Am Soc Hematol Educ Progr. 2018 Nov;2018(1):382-9.

6. Zarandona JM, Yazer MH. The role of the Coombs test in evaluating hemolysis in adults. C Can Med Assoc J = J l’Association medicale Can. 2006 Jan;174(3):305-7.

7. Hendrickson JE, Tormey CA. COVID-19 and the Coombs test. Blood. 2020 Aug;136(6):655-6.

8. Lopez C, Kim J, Pandey A, Huang T, DeLoughery TG. Simultaneous onset of COVID-19 and autoimmune haemolytic anaemia. British journal of haematology. 2020;190:31-2.

9. Lazarian G, Quinquenel A, Bellal M, Siavellis J, Jacquy C, Re D, et al. Autoimmune haemolytic anaemia associated with COVID-19 infection. British journal of haematology. 2020;190:29-31.

10. Hindilerden F, Yonal-Hindilerden I, Akar E, Yesilbag Z, Kart-Yasar K. Severe Autoimmune Hemolytic Anemia in COVID-19 İnfection, Safely Treated with Steroids. Mediterr J Hematol Infect Dis. 2020;12(1):e2020053.

11. Wahlster L, Weichert-Leahey N, Trissal M, Grace RF, Sankaran VG. COVID-19 presenting with autoimmune hemolytic anemia in the setting of underlying immune dysregulation. Pediatric blood & cancer. 2020;67:e28382.

12. Maslov D V, Simenson V, Jain S, Badari A. COVID-19 and Cold Agglutinin Hemolytic Anemia. TH open : companion journal to thrombosis and haemostasis. 2020;4:e175-7.

13. Zagorski E, Pawar T, Rahimian S, Forman D. Cold agglutinin autoimmune haemolytic anaemia associated with novel coronavirus (COVID-19). British journal of haematology. 2020;190:e183-4.

14. Chibane S, Gibeau G, Poulin F, Tessier P, Goulet M, Carrier M, et al. Hyperacute multi-organ thromboembolic storm in COVID-19: a case report. J Thromb Thrombolysis. 2021 Jan;51(1):25-8.

15. Patil NR, Herc ES, Girgis M. Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection. Hematology/ oncology and stem cell therapy. 2020.

16. Capes A, Bailly S, Hantson P, Gerard L, Laterre P-F. COVID- 19 infection associated with autoimmune hemolytic anemia. Ann Hematol [Internet]. 2020 Jul;99(7):1679-80. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32542444

17. Jensen CE, Wilson S, Thombare A, Weiss S, Ma A. Cold agglutinin syndrome as a complication of Covid-19 in two cases. Clinical infection in practice. 2020;7:100041.

18. Secretaría de Salud. Comunicado Técnico Diario Nuevo Coronavirus en el Mundo (COVID-19) [Internet]. 2021 Jun [consultado: 27 de octubre de 2021]. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/643634/ Comunicado_Tecnico_Diario_COVID-19_2021.06.03.pdf